Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan H Lazarus

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2018
Erythrocyte Saturation with IgG Is Required for Inducing Antibody-Mediated Immune Suppression and Impacts Both Erythrocyte Clearance and Antigen-Modulation MechanismsYoelys Cruz-Leal, Danielle Marjoram, Alan H Lazarus
Current Opinion in Hematology|September 5, 2009
Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models?Davor Brinc, Gregory A Denomme, Alan H Lazarus
Transfusion|February 21, 2023
Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine modelHanna Wabnitz, Yoelys Cruz-Leal, Alan H Lazarus
Current Opinion in Hematology|September 2, 2020
New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseasesPeter A A Norris, Gurleen Kaur, Alan H Lazarus
Blood|June 23, 2016
Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in miceLidice Bernardo, Alaa Amash, Danielle Marjoram, et al.
Seminars in Hematology|May 14, 2013
Innate and adaptive immunity in immune thrombocytopeniaAlan H Lazarus, John W Semple, Douglas B Cines
Plos One|August 14, 2013
Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathwayAndrew R Crow, Honghui Yu, Dongji Han, et al.
Advances in Hematology|January 29, 2015
RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive ErythrocytesLidice Bernardo, Gregory A Denomme, Kunjlata Shah, et al.
Pediatric Blood & Cancer|August 26, 2006
Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopeniaAndrew R Crow, Seng Song, Vinayakumar Siragam, et al.
Blood|July 20, 2002
Gamma-globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune responseJohn W Semple, Michael Kim, Alan H Lazarus, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2018
Erythrocyte Saturation with IgG Is Required for Inducing Antibody-Mediated Immune Suppression and Impacts Both Erythrocyte Clearance and Antigen-Modulation MechanismsYoelys Cruz-Leal, Danielle Marjoram, Alan H Lazarus
Current Opinion in Hematology|September 5, 2009
Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models?Davor Brinc, Gregory A Denomme, Alan H Lazarus
Transfusion|February 21, 2023
Antigen copy number and antibody dose can determine the outcome of erythrocyte alloimmunization inducing either antibody-mediated immune suppression or enhancement in a murine modelHanna Wabnitz, Yoelys Cruz-Leal, Alan H Lazarus
Current Opinion in Hematology|September 2, 2020
New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseasesPeter A A Norris, Gurleen Kaur, Alan H Lazarus
Blood|June 23, 2016
Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in miceLidice Bernardo, Alaa Amash, Danielle Marjoram, et al.
Seminars in Hematology|May 14, 2013
Innate and adaptive immunity in immune thrombocytopeniaAlan H Lazarus, John W Semple, Douglas B Cines
Plos One|August 14, 2013
Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathwayAndrew R Crow, Honghui Yu, Dongji Han, et al.
Advances in Hematology|January 29, 2015
RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive ErythrocytesLidice Bernardo, Gregory A Denomme, Kunjlata Shah, et al.
Pediatric Blood & Cancer|August 26, 2006
Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopeniaAndrew R Crow, Seng Song, Vinayakumar Siragam, et al.
Blood|July 20, 2002
Gamma-globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune responseJohn W Semple, Michael Kim, Alan H Lazarus, et al.
Pageof 8